A total of 16 covered entities (CEs) owe repayment to drugmakers, five more than reported a month ago, according to [...] …
Month: October 2023
More than 400 hospitals risk losing 340B eligibility if Congress does not extend exemptions authorized during the public health emergency [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
If you have one or more agreements with 340B Third Party Administrator(s) (TPA) to manage your contract pharmacy arrangements, how much do you know about those contracts and associated fees? Chances are, you don’t know the answers to all the questions that follow. Be sure to contact your 340B TPA(s) and ask:
- How does the TPA charge your covered entity to perform its services? Is it a flat monthly fee per contract pharmacy, a flat fee plus a percentage of savings on 340B approved claims, a percentage of savings, a captured claim fee, or per matched charge?
- Does your TPA agreement have a minimum dollar amount threshold for administrative fees per contract pharmacy?
- Are you being charged for switch fees (If your covered entity is being charged for switch fees, do you know what the average switch fee cost is to compare to what you are being charged?), gateway fees, or a
The majority of 340B disproportionate share hospitals (DSH) provide charity care at lower rates than the national hospital average, found [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Timelines for manufacturers to provide new Medicare “maximum fair prices” (MFPs) and 340B ceiling prices on drugs are misaligned, risking [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
TIP: It is critical to ensure that ONLY items your Covered Entity (CE) considers eligible are included in the data file that is
Japanese pharmaceutical manufacturer Eisai will not limit hospital 340B contract pharmacy use in Arkansas and Louisiana after its new contract [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Drugmaker Bristol Myers Squibb added new language to its latest 340B contract pharmacy policy notice, which appears to target hospital [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
SPONSORED CONTENT
Despite calls for reform by opponents, 340B enjoys broad bipartisan support. On the legislative front, lawmakers have introduced multiple bills in the House and Senate that, if enacted, would alter program operations. Multiple court cases regarding contract pharmacy use are working their way through the judicial system. Coalitions for and against changes are continuing to make their best case in front of Congress and federal regulators. In the current environment, AIDS Healthcare Foundation navigates these complex political and legal challenges to ensure 340B functions as a health and wellness multiplier for its over 56,000 patients living with HIV.
A flurry of 340B-specific legislation and broader healthcare reform packages find themselves in different stages of the legislative process. In the House, The PROTECT 340B Act of 2023, sponsored by Reps. Abigail Spanberger (D-VA) and Dusty Johnson (R-SD), has attracted 16 co-sponsors, but has yet to receive a vote and remains stuck in committee; the bill prohibits
…
The deadline has passed for two health systems to respond to an influential senator’s probe into 340B revenue, and at [...] …